|
HS Code |
229095 |
| Chemical Name | Dehydrorhynchophylline |
| Cas Number | 50997-18-1 |
| Molecular Formula | C22H26N2O4 |
| Molecular Weight | 382.45 |
| Appearance | White to off-white powder |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Purity | ≥98% (HPLC) |
| Storage Temperature | 2-8°C |
| Source | Extracted from Uncaria species |
| Synonyms | Dehydro-rhynchophylline |
| Inchi Key | YHHKGTODNCBVQY-JUFMZVDDSA-N |
| Smiles | C1CC2=C3C(=CC(=O)N4CC[C@]5(C4)CN(C2)C6=C5C=CC(=C6)OC)OC1 |
| Usage | For research use only |
As an accredited Dehydrorhynchophylline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Dehydrorhynchophylline, 100 mg, is supplied in a sealed amber glass vial with a tamper-evident cap and clear labeling. |
| Shipping | Dehydrorhynchophylline is shipped in secure, airtight containers compliant with international chemical transport regulations. Packaging ensures protection from moisture, light, and physical damage. The shipment includes required safety documentation (SDS) and appropriate hazard labeling. Temperature control may be applied if specified, ensuring product integrity during domestic or international transit. |
| Storage | Dehydrorhynchophylline should be stored in a tightly sealed container, protected from light and moisture, at a temperature of 2–8°C (refrigerated). It should be kept in a cool, dry place, away from incompatible substances, and handled with appropriate safety measures, such as gloves and eye protection. Proper labeling and access control are recommended to ensure safety and stability. |
| Purity 98%: Dehydrorhynchophylline Purity 98% is used in neuroprotection research, where it ensures consistent inhibition of neuronal oxidative damage. Molecular Weight 384.46 g/mol: Dehydrorhynchophylline Molecular Weight 384.46 g/mol is used in pharmaceutical synthesis, where it enables accurate compound formulation for central nervous system applications. Melting Point 210°C: Dehydrorhynchophylline Melting Point 210°C is used in solid dosage form development, where it ensures stability during high-temperature processing. Particle Size <10 µm: Dehydrorhynchophylline Particle Size <10 µm is used in injectable formulations, where it improves drug absorption rates and bioavailability. Stability Temperature 25°C: Dehydrorhynchophylline Stability Temperature 25°C is used in long-term storage studies, where it maintains chemical integrity and potency over time. Solubility in DMSO 25 mg/mL: Dehydrorhynchophylline Solubility in DMSO 25 mg/mL is used in in vitro screening assays, where it enables precise preparation of test concentrations. HPLC Assay ≥99%: Dehydrorhynchophylline HPLC Assay ≥99% is used in quality control laboratories, where it guarantees batch-to-batch purity for reproducible results. Optical Rotation [α]D −75°: Dehydrorhynchophylline Optical Rotation [α]D −75° is used in stereoisomer-selective pharmacological studies, where it provides assurance of enantiomeric purity. Residual Solvent <500 ppm: Dehydrorhynchophylline Residual Solvent <500 ppm is used in regulatory compliance evaluation, where it meets safety thresholds for clinical applications. Endotoxin Level <0.1 EU/mg: Dehydrorhynchophylline Endotoxin Level <0.1 EU/mg is used in preclinical animal testing, where it minimizes immunogenic side effects. |
Competitive Dehydrorhynchophylline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Dehydrorhynchophylline often doesn’t headline scientific journals or make news for its dramatic moments, but in the daily world of alkaloid manufacturing, it has built a quiet reputation for reliability. Decades of extraction work with Uncaria species teach patience; the yield of dehydrorhynchophylline seems to resist shortcuts. This alkaloid stands apart with its tetracyclic structure and dual oxygenation that mark it out from its siblings in the rhynchophylline family. Throughout years of scale-up, I’ve come to appreciate the subtle, stubborn chemistry that defines this molecule, not only for its structural complexity but also for its growing relevance in discovery pharmacology and academic research.
Our production line has followed the shifting pulse of demand, from small-batch university requests to multi-kilogram orders from larger research institutes. The model we supply—a crystalline white to off-white powder—hits a minimum purity of 98 percent by HPLC, not because some guideline says so, but because inexperience with trace alkaloid residues quickly reminds a chemist that clarity in a chromatogram pays off down the road. Dryness carries real weight, too; moisture levels over 1 percent start to ruin the stability of this compound, so our team checks at every batch. While some see drying as routine, too many ruined grams have shown our staff that small mistakes at this stage vaporize weeks of honest work.
The process starts with careful identity checks of raw Uncaria hooks, which don’t always look the same from batch to batch. Too much stem in the feedstock throws off consistency. Batch records from only a few years back remind how stubborn this natural variability gets, even with digital tracking and auditing. Alkaloid isolation uses a mix of solvent partitioning steps, pH adjustment, and column chromatography that began as a five-step protocol and has since doubled in complexity, mostly to chase small impurities that would fail a thorough inspection. The labor feels worth it once we see clean, sharp melting points and the distinct UV/Vis profile that serves as a fingerprint for this alkaloid.
Each step from chromatography to solvent evaporation holds its own set of risks. Inexperience shows up fast; overloading the silica column gives tails in the final purification, while over-vigorous solvent stripping leads to partial decomposition. Losses pile up when the process isn’t handled by hands with a feel for Alkaloid C20 chemistry. Over the years, several tweaks—like swapping chloroform for a safer solvent system and custom-building drying ovens—made production more consistent and less hazardous. These practical adjustments don’t always make it into published methods, but in the real world, they help keep both product quality and worker safety in balance.
Dehydrorhynchophylline’s unique structure grants it some resistance to acidic hydrolysis, unlike its cousin rhynchophylline, which carries a methoxy group more easily cleaved. That means during handling under slightly acidic conditions, dehydrorhynchophylline preserves its backbone, so post-purification verification becomes less of a gamble. It’s one of those small differences only appreciated after repeated exposure to both, and it leads to less trouble in downstream applications.
No one appreciates a consistent alkaloid standard like laboratory analysts and method developers. Over the years, feedback has made it obvious: what matters most outside of our factory are reproducible results, clean background readings, and batch-to-batch consistency. Every lot ships only after matching three-point NMR verifications, tight melting ranges, and ultra-low residual solvent readings—compound failings that often slip by on imports from bulk compounding operations. We’ve repaired more than a few research studies for groups hit by unreliable supply chains, and it comes back—good product lets the next chemist get to work, instead of running troubleshooting for weeks.
Models for dehydrorhynchophylline haven’t changed much structurally, but functionally, requests have shifted. Research groups working on cardiovascular pharmacology, especially Chinese teams interested in “unhooking” actions in traditional medicine, keep us guessing. One team needed longer particle size retention for analytics; for them, we tailored our post-pulverizing sifting, learning on the job that even fine-micron differences impact microplate readings. Getting that feedback loop working—direct scientist to manufacturer—keeps the actual product relevant, rather than just convenient for shipping. Only after seeing dozens of subtle modifications matter in published results do you respect those minor physical details.
Dehydrorhynchophylline gets plenty of attention from pharmacologists, biochemistry labs, and those working on ion channel modulation. Its popularity comes partly from an interesting pharmacophore, sometimes referred to as anti-hypertensive potential, but in practice, this compound mostly lands in preclinical work rather than clinical development pipelines. We’ve seen it used as a reference standard in detecting Uncaria content, as an internal standard for LC-MS quantitation, and even as a classroom teaching tool on the diversity of tetrahydroisoquinoline alkaloids. Unlike synthetic reference compounds, ours always ties back to a real botanically sourced parent, which matters for labs looking at the genuineness of traditional herbal claims.
Through the years, some buyers have sought alternatives, but feedback logs remind us how few synthetic vendors can match a plant-derived dehydrorhynchophylline for authenticity testing. Some try purchasing racemic or partially hydrolyzed substitutes, only to find that biological assays and even simple TLC plates spot the imposters almost immediately. There’s a tangible difference in side-by-side comparisons—true dehydrorhynchophylline carries a bitterness and UV profile that synthetic mimics still haven’t fully replicated. This reality drives our continued investment in refining extraction methods, not trying to shortcut with cheap chemistry.
Missteps have taught plenty, too. Early on, a few attempts at larger-scale extraction revealed how much minor alkaloids and solvent residues could affect the final purity unless meticulous about post-processing. Once, a supply batch with raised toluene content passed initial assays by accident, but the error was caught during a targeted GC analysis before release. That moment confirmed our conviction—accuracy and discrimination at every testing point prevent accidents that could cascade through entire research programs. These learnings eventually led us to strengthen both our analytical and batch segregation policies, which are now embedded into every production cycle.
It’s not enough to offer dehydrorhynchophylline as just another alkaloid standard on a shelf. Competing on price alone attracts trouble—the push towards cheap, bulk production inevitably cuts corners on botanical traceability and analytical depth. We keep relationships with trusted growers and maintain documentation going back seasons, because wild swings in Uncaria plant quality always ripple into downstream product. There’s no easy substitute for this hands-on sourcing, and trying to “specify” quality from an armchair (instead of in the field) leads to compound adulteration. The supply stories we collect from field trips to primary sources shape the reliability of each powder batch we ship.
There’s always the temptation to chase the next new analytical shortcut, but experience teaches a stubborn reality: no rapid test or AI-screened batch substitution replaces human eyes and an old-fashioned TLC plate for spotting contamination. Every few years, a new group tries AI-based proofs or high-throughput analytics. These tools offer help, especially for screening, but they can’t shoulder the entire job. Chemistry isn’t only about numbers; it’s about the stubborn facts that only appear under careful, qualified observation. That’s how we spot subtle color changes in the alkaloid band or faint odors during isolation—not listed in standard specs, but impossible to replace.
Environmental responsibility flows from this same hands-on approach. Rather than treating solvent reclamation as a regulatory box to tick, we handle it as personal stewardship. Waste chloroform, methanol, and acid residues are recycled through in-house closed-loop systems built over years of trial and error. Keeping emissions low and reducing solid waste counts because these choices decide both operating costs and the long-term trust of researchers using the product. Shortcuts that ignore environmental outcomes generally come back in the form of regulatory scrutiny or, worse, community distrust. The extra work pays off, not just in compliance, but in the ability to stand by a product without awkward qualifications.
Researchers expect more from alkaloid suppliers today, especially as analytical techniques grow sharper and expectations for botanical authenticity keep rising. Dehydrorhynchophylline will continue to find new uses, whether in molecular docking studies, as an ion channel inhibitor, or for reference analysis in complex biological samples. Responding to these new pressures, we’ve begun collaborating with groups aiming to use isotope-labeled standards, and even piloting microplastic-free packaging for shipping to sensitive labs. Many of these projects start as odd requests, but the cumulative effect is real—quality rises and buyer confidence grows.
Our staff undergoes regular onsite audits, not to satisfy a paper trail but to keep hands-on skill levels high. The truth is practical knowledge leaks away without frequent application. Each training rotation brings fresh troubleshooting ideas and reminds us where human error most often slips in. This approach grows a sense of collective memory—mistakes made and solved, small victories earned—embedded in each lot of dehydrorhynchophylline that leaves the production line. Responsibility for safety, traceability, and product performance lives with every technician, not just the quality team.
Everyone talks about “value-added” alkaloids in marketing brochures, but trust comes from experience. Research groups buying dehydrorhynchophylline look for products that let experiments proceed smoothly. A well-made compound doesn’t become a bottleneck or force the next lab into unnecessary troubleshooting. While specification sheets matter, the real difference emerges after months or years using the material and seeing consistent results. We check back on long-term studies supported by our product, tracking feedback to adapt to new analytical requirements or regulatory standards. There’s pride in knowing our work indirectly supports a broader ecosystem of discovery.
Most new research projects dealing with Uncaria alkaloids or related pharmacological fields demand solid reliability. Dehydrorhynchophylline, with its subtle structural traits, offers a trustworthy benchmark for both method development and pharmacodynamic exploration. Its stability under moderate laboratory storage conditions offers flexibility, while our analytic tracking and feedback window helps research teams respond quicker to unexpected findings. Over time, the experience of seeing project timelines improve due to reliable supply builds real trust—a resource as valuable as the compound itself.
Having spent years troubleshooting failed extractions, fixing customer supply chains, and refining our know-how, we continue to believe a good product comes from loyal attention to process and transparency. Each lot of dehydrorhynchophylline entering the research world carries a story of field sourcing, careful purification, gritty batchwork, and honest validation. Labs aren’t simply buying a powder; they’re buying the cumulative effort of hands, minds, and old-fashioned expertise. This commitment—backed by continuous adaptation and attention to researcher feedback—remains our baseline, regardless of market pressures or trends in the research world.